Riskpilot← Back to searchSign inGet full accessDRØBAK ØRE NESE HALS AS
ASActiveOrg 998516633Storgata 27, 1440 DrøbakMedical specialists activities · NACE 8622Est. 20129 employees
Revenue 2025
NOK 5,2M
-2% vs 2024
EBITDA margin
0.7%
-91% vs 2024
Equity ratio
-12.7%
Financial strength
Net profit 2025
NOK 0
-100% vs 2024
| Revenue | NOK 5,2M | -2% |
| EBITDA | NOK 36K | -91% |
| Net profit | NOK 0 | -100% |
| Total assets | NOK 661K | +21% |
| Equity | NOK -84K | +0% |
| Employees | 9 | — |
Legal name
DRØBAK ØRE NESE HALS AS
Org number
998516633
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
19. juni 2012
Share capital
NOK 30 000
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Spesialpraktiserende legevirksomhet innen øre, nese, hals.
Address
Storgata 27, 1440 Drøbak
Phone
+4764905920
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 847 | 4 542 | 5 302 | 5 286 | 5 184 |
| Staff expenses | −2 611 | −2 365 | −2 370 | −2 827 | −3 107 |
| EBITDA | 77 | −146 | −552 | 404 | 36 |
| Depreciation & amort. | −105 | −23 | −23 | −31 | −35 |
| EBIT | −28 | −169 | −575 | 373 | 1 |
| Net financials | −0 | −0 | −0 | −1 | −1 |
| Profit before tax | −29 | −169 | −575 | 372 | 0 |
| Tax | −6 | −37 | −126 | 83 | −0 |
| Net profit | −22 | −132 | −449 | 290 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 910 | 763 | 431 | 548 | 661 |
| Equity | 207 | 75 | −374 | −84 | −84 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 703 | 688 | 805 | 631 | 744 |
| Total debt | 703 | 688 | 805 | 631 | 744 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20212025
Equity ratio
-12.7%
This company
38.2%
Market median
-133% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
7.85×
This company
1.12×
Market median
+601% vs market
20212025
Debt / equity
8.89×
This company
0.62×
Market median
-1334% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ØS Chief Executive Officer | Chief Executive Officer | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DRØBAK ØRE NESE HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Øystein Shahin Eskeland | Chief Executive Officer | 0 companies |
| Kalle-Kustaa Hemiö | Board of Directors | 0 companies |
| Agnes Beate Morland Hemiö | Board of Directors | 0 companies |
| Katrine Kleven | Board of Directors | 0 companies |